Cargando…
The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus
AIMS: Previous studies showed conflicting relationship between hyperlipidemia, lipid-lowering therapy and diabetic peripheral neuropathy (DPN). As most of these works emerges from the Western and Australian countries, our study aims to investigate whether hyperlipidemia or lipid-lowering therapy (LL...
Autores principales: | Chang, Kuo-Cheng, Pai, Yen-Wei, Lin, Ching-Heng, Lee, I-Te, Chang, Ming-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270586/ https://www.ncbi.nlm.nih.gov/pubmed/37319238 http://dx.doi.org/10.1371/journal.pone.0287373 |
Ejemplares similares
-
Reconfirmation of newly discovered risk factors of diabetic peripheral neuropathy in patients with type 2 diabetes: A case-control study
por: Pai, Yen-Wei, et al.
Publicado: (2019) -
Renal impairment is one of appropriate predictors of future diabetic peripheral neuropathy: a hospital-based 6-year follow-up study
por: Wang, Chi-Sheng, et al.
Publicado: (2022) -
Lipid-lowering drugs (statins) and peripheral neuropathy
por: Emad, Mohammadreza, et al.
Publicado: (2018) -
Diabetic Peripheral Neuropathy in Type 2 Diabetes Mellitus in Korea
por: Ko, Seung-Hyun, et al.
Publicado: (2012) -
Correlation between Acylcarnitine and Peripheral Neuropathy in Type 2 Diabetes Mellitus
por: An, Zhenni, et al.
Publicado: (2022)